COVID-19-associated Guillain-Barre syndrome: Postinfectious alone or neuroinvasive too?

44Citations
Citations of this article
97Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Coronavirus disease 2019 (COVID-19) has been shown to be associated with a lot of neurological complications, of whom Guillain-Barre syndrome (GBS) is an important post-infectious consequentiality. More than 220 patients with GBS have been reported thus far. We intend to share our experience with five patients of GBS where one of them had severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the cerebrospinal fluid (CSF). This is the first-ever report demonstrating the presence of SARS-CoV-2 in the CSF of an adult patient; a similar occurrence has recently been described in a pediatric patient. We wish to emphasize the fact that commonly GBS occurs as a result of a post-infectious process but in a few cases where the symptoms of COVID-19 and GBS occur concurrently, corresponding to the viremic phase, separate pathogenesis needs to be thought of. This para-infectious nature is exemplified by the presence of virus in the cerebrospinal fluid of one of our patients. We review the neuroinvasive potential of SARS-Cov-2 in this regard and draw parallels with Cytomegalovirus, Zika virus, and Human Immunodeficiency virus-associated occurrences of GBS.

Cite

CITATION STYLE

APA

Khan, F., Sharma, P., Pandey, S., Sharma, D., Vijayavarman, V., Kumar, N., … Malhotra, H. S. (2021). COVID-19-associated Guillain-Barre syndrome: Postinfectious alone or neuroinvasive too? Journal of Medical Virology, 93(10), 6045–6049. https://doi.org/10.1002/jmv.27159

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free